Growth Metrics

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2025)

Collegium Pharmaceutical (COLL) has 9 years of Amortizatization of Intangibles data on record, last reported at -$165.3 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 398.08% year-over-year to -$165.3 million; the TTM value through Dec 2025 reached $1.1 million, down 99.35%, while the annual FY2025 figure was $1.1 million, 99.35% down from the prior year.
  • Amortizatization of Intangibles reached -$165.3 million in Q4 2025 per COLL's latest filing, down from $110.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $110.6 million in Q3 2025 and bottomed at -$165.3 million in Q4 2025.
  • Average Amortizatization of Intangibles over 5 years is $25.8 million, with a median of $35.4 million recorded in 2023.
  • The widest YoY moves for Amortizatization of Intangibles: up 171.13% in 2025, down 398.08% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $16.8 million in 2021, then surged by 151.74% to $42.3 million in 2022, then fell by 18.37% to $34.5 million in 2023, then surged by 60.72% to $55.5 million in 2024, then tumbled by 398.08% to -$165.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$165.3 million in Q4 2025, $110.6 million in Q3 2025, and $55.5 million in Q2 2025.